Dr. Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco currently serves as Chief Medical Officer, Providence Genomics, and as Member and Director of Translational Molecular Pathology and Molecular Genomics at the Earle A. Chiles Research Institute in Portland, Oregon, a division of Providence Cancer Institute. He oversees Providence Molecular Genomics Laboratory, which provides state-of-the-art genomic sequencing to cancer patients. His current translational research is focused on immunohistochemical and image analysis techniques, and on the integration of genomics with immunotherapies. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC), and is Co-Chair of the SITC Pathology Task Force.
Ari Robicsek, MD, is chief medical analytics officer and senior VP of Research at Providence, a 52-hospital physician health care system based on the West Coast of the United States. His team focuses on democratizing data, innovating analytical technology, and linking health services researchers with clinicians and healthcare operators. Formerly, he was VP of Clinical Analytics at NorthShore University HealthSystem in Evanston, Illinois, and in 2017, he was one of Health Data Management's Top 25 Physician IT leaders. Ari’s academic work has been published in JAMA, Annals of Internal Medicine, and other journals. He has co-chaired Epic’s Research Advisory Council and Data Scientist Forums. Dr. Robicsek received his medical degree from the University of Toronto Medical School, where he also served his internship and residency. He completed a fellowship in infectious diseases at Harvard Medical School.